Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 385

1.

Cholesterol and Its Metabolites in Tumor Growth: Therapeutic Potential of Statins in Cancer Treatment.

Chimento A, Casaburi I, Avena P, Trotta F, De Luca A, Rago V, Pezzi V, Sirianni R.

Front Endocrinol (Lausanne). 2019 Jan 21;9:807. doi: 10.3389/fendo.2018.00807. eCollection 2018. Review.

2.

How Do Drug Regulatory Bodies Deal With Potential Innovative Therapies?

Tutone M, Villa F, Addis A, Trotta F, Tafuri G.

Ther Innov Regul Sci. 2019 Jan 28:2168479018820889. doi: 10.1177/2168479018820889. [Epub ahead of print]

PMID:
30691286
3.

Ailanthone inhibits cell growth and migration of cisplatin resistant bladder cancer cells through down-regulation of Nrf2, YAP, and c-Myc expression.

Daga M, Pizzimenti S, Dianzani C, Cucci MA, Cavalli R, Grattarola M, Ferrara B, Scariot V, Trotta F, Barrera G.

Phytomedicine. 2018 Oct 29;56:156-164. doi: 10.1016/j.phymed.2018.10.034. [Epub ahead of print]

PMID:
30668336
4.

Lipid- and polymer-based plexes as therapeutic carriers for bioactive molecules.

Shende P, Ture N, Gaud RS, Trotta F.

Int J Pharm. 2019 Mar 10;558:250-260. doi: 10.1016/j.ijpharm.2018.12.085. Epub 2019 Jan 12. Review.

PMID:
30641179
5.

Information needs on precision medicine: a survey of Italian health care professionals.

Addis A, Trotta F, Tafuri G, De Fiore L.

Ann Ist Super Sanita. 2018 Oct-Dec;54(4):316-323. doi: 10.4415/ANN_18_04_08.

6.

Glutathione/pH-responsive nanosponges enhance strigolactone delivery to prostate cancer cells.

Argenziano M, Lombardi C, Ferrara B, Trotta F, Caldera F, Blangetti M, Koltai H, Kapulnik Y, Yarden R, Gigliotti L, Dianzani U, Dianzani C, Prandi C, Cavalli R.

Oncotarget. 2018 Nov 9;9(88):35813-35829. doi: 10.18632/oncotarget.26287. eCollection 2018 Nov 9.

7.

Open abdomen and entero-atmospheric fistulae: An interim analysis from the International Register of Open Abdomen (IROA).

Coccolini F, Ceresoli M, Kluger Y, Kirkpatrick A, Montori G, Salvetti F, Fugazzola P, Tomasoni M, Sartelli M, Ansaloni L, Catena F, Negoi I, Zese M, Occhionorelli S, Shlyapnikov S, Galatioto C, Chiarugi M, Demetrashvili Z, Dondossola D, Ioannidis O, Novelli G, Nacoti M, Khor D, Inaba K, Demetriades D, Kaussen T, Jusoh AC, Ghannam W, Sakakushev B, Guetta O, Dogjani A, Costa S, Singh S, Damaskos D, Isik A, Yuan KC, Trotta F, Rausei S, Martinez-Perez A, Bellanova G, Fonseca V, Hernández F, Marinis A, Fernandes W, Quiodettis M, Bala M, Vereczkei A, Curado R, Fraga GP, Pereira BM, Gachabayov M, Chagerben GP, Arellano ML, Ozyazici S, Costa G, Tezcaner T, Porta M, Li Y, Karateke F, Manatakis D, Mariani F, Lora F, Sahderov I, Atanasov B, Zegarra S, Gianotti L, Fattori L, Ivatury R.

Injury. 2019 Jan;50(1):160-166. doi: 10.1016/j.injury.2018.09.040. Epub 2018 Sep 24.

PMID:
30274755
8.

Encapsulation of Babchi Oil in Cyclodextrin-Based Nanosponges: Physicochemical Characterization, Photodegradation, and In Vitro Cytotoxicity Studies.

Kumar S; Pooja, Trotta F, Rao R.

Pharmaceutics. 2018 Sep 26;10(4). pii: E169. doi: 10.3390/pharmaceutics10040169.

9.

Cholesterol as an Endogenous ERRα Agonist: A New Perspective to Cancer Treatment.

Casaburi I, Chimento A, De Luca A, Nocito M, Sculco S, Avena P, Trotta F, Rago V, Sirianni R, Pezzi V.

Front Endocrinol (Lausanne). 2018 Sep 11;9:525. doi: 10.3389/fendo.2018.00525. eCollection 2018. Review.

10.

Alterations of Hyaluronan Metabolism in Acute Coronary Syndrome: Implications for Plaque Erosion.

Pedicino D, Vinci R, Giglio AF, Pisano E, Porto I, Vergallo R, Russo G, Ruggio A, D'Aiello A, Flego D, Annibali G, Trotta F, Piacentini R, Niccoli G, Liuzzo G, Crea F.

J Am Coll Cardiol. 2018 Sep 25;72(13):1490-1503. doi: 10.1016/j.jacc.2018.06.072.

PMID:
30236312
11.

Neonatal outcomes following new reimbursement limitations on palivizumab in Italy.

Belleudi V, Trotta F, Pinnarelli L, Davoli M, Addis A.

Arch Dis Child. 2018 Dec;103(12):1163-1167. doi: 10.1136/archdischild-2018-315349. Epub 2018 Sep 14.

12.

Controlled Release of DEET Loaded on Fibrous Mats from Electrospun PMDA/Cyclodextrin Polymer.

Cecone C, Caldera F, Trotta F, Bracco P, Zanetti M.

Molecules. 2018 Jul 11;23(7). pii: E1694. doi: 10.3390/molecules23071694.

13.

Inflammasome, T Lymphocytes and Innate-Adaptive Immunity Crosstalk: Role in Cardiovascular Disease and Therapeutic Perspectives.

Pedicino D, Giglio AF, Ruggio A, Massaro G, D'Aiello A, Trotta F, Lucci C, Graziani F, Biasucci LM, Crea F, Liuzzo G.

Thromb Haemost. 2018 Aug;118(8):1352-1369. doi: 10.1055/s-0038-1666860. Epub 2018 Jul 10.

PMID:
29991092
14.

Investigation of Cyclodextrin-Based Nanosponges for Solubility and Bioavailability Enhancement of Rilpivirine.

Rao MRP, Chaudhari J, Trotta F, Caldera F.

AAPS PharmSciTech. 2018 Jul;19(5):2358-2369. doi: 10.1208/s12249-018-1064-6. Epub 2018 Jun 4.

PMID:
29869305
15.

Cyclic nigerosyl-1,6-nigerose-based nanosponges: An innovative pH and time-controlled nanocarrier for improving cancer treatment.

Caldera F, Argenziano M, Trotta F, Dianzani C, Gigliotti L, Tannous M, Pastero L, Aquilano D, Nishimoto T, Higashiyama T, Cavalli R.

Carbohydr Polym. 2018 Aug 15;194:111-121. doi: 10.1016/j.carbpol.2018.04.027. Epub 2018 Apr 6.

PMID:
29801818
16.

Studies on drug switchability showed heterogeneity in methodological approaches: a scoping review.

Belleudi V, Trotta F, Vecchi S, Amato L, Addis A, Davoli M.

J Clin Epidemiol. 2018 Sep;101:5-16. doi: 10.1016/j.jclinepi.2018.05.003. Epub 2018 May 16. Review.

17.

Pattern of Use of Biosimilar and Originator Somatropin in Italy: A Population-Based Multiple Databases Study During the Years 2009-2014.

Marcianò I, Ingrasciotta Y, Giorgianni F, Ientile V, Chinellato A, Tari DU, Gini R, Cannavò S, Pastorello M, Scondotto S, Cananzi P, Traversa G, Trotta F, Belleudi V, Addis A, Trifirò G.

Front Endocrinol (Lausanne). 2018 Mar 13;9:95. doi: 10.3389/fendo.2018.00095. eCollection 2018.

18.

Population-based cohort study on comparative effectiveness and safety of biologics in inflammatory bowel disease.

Di Domenicantonio R, Trotta F, Cascini S, Agabiti N, Kohn A, Gasbarrini A, Davoli M, Addis A.

Clin Epidemiol. 2018 Feb 5;10:203-213. doi: 10.2147/CLEP.S150030. eCollection 2018.

19.

GPER-independent inhibition of adrenocortical cancer growth by G-1 involves ROS/Egr-1/BAX pathway.

Casaburi I, Avena P, De Luca A, Sirianni R, Rago V, Chimento A, Trotta F, Campana C, Rainey WE, Pezzi V.

Oncotarget. 2017 Dec 14;8(70):115609-115619. doi: 10.18632/oncotarget.23314. eCollection 2017 Dec 29.

20.

Cyclodextrin-based nanosponges as vehicles for antiviral drugs: challenges and perspectives.

Lembo D, Trotta F, Cavalli R.

Nanomedicine (Lond). 2018 Mar;13(5):477-480. doi: 10.2217/nnm-2017-0383. Epub 2018 Jan 29. No abstract available.

21.

Indoleamine 2,3-Dioxygenase (IDO) Enzyme Links Innate Immunity and Altered T-Cell Differentiation in Non-ST Segment Elevation Acute Coronary Syndrome.

Zara C, Severino A, Flego D, Ruggio A, Pedicino D, Giglio AF, Trotta F, Lucci C, D'Amario D, Vinci R, Pisano E, La Rosa G, Biasucci LM, Crea F, Liuzzo G.

Int J Mol Sci. 2017 Dec 26;19(1). pii: E63. doi: 10.3390/ijms19010063.

22.

Matrix metalloproteinase-9 might affect adaptive immunity in non-ST segment elevation acute coronary syndromes by increasing CD31 cleavage on CD4+ T-cells.

Angelini G, Flego D, Vinci R, Pedicino D, Trotta F, Ruggio A, Piemontese GP, Galante D, Ponzo M, Biasucci LM, Liuzzo G, Crea F.

Eur Heart J. 2018 Apr 1;39(13):1089-1097. doi: 10.1093/eurheartj/ehx684.

23.

Comparing safety information of biosimilars with their originators: a cross-sectional analysis of European risk management plans.

Lepelaars LRA, Renda F, Pani L, Pimpinella G, Leufkens HGM, Trifirò G, Tafuri G, Mantel-Teeuwisse AK, Trotta F.

Br J Clin Pharmacol. 2018 Apr;84(4):738-763. doi: 10.1111/bcp.13454. Epub 2018 Jan 18.

PMID:
29164665
24.

[Which efficacy trials for drugs for rare diseases?]

Traversa G, Trotta F.

Epidemiol Prev. 2017 Sep-Dec;41(5-6):318-319. doi: 10.19191/EP17.5-6.P318.099. Italian. No abstract available.

PMID:
29119773
25.

Comparative efficacy and safety in ESA biosimilars vs. originators in adults with chronic kidney disease: a systematic review and meta-analysis.

Amato L, Addis A, Saulle R, Trotta F, Mitrova Z, Davoli M.

J Nephrol. 2018 Jun;31(3):321-332. doi: 10.1007/s40620-017-0419-5. Epub 2017 Jun 23. Review.

PMID:
28646375
26.

Evolution of Cyclodextrin Nanosponges.

Caldera F, Tannous M, Cavalli R, Zanetti M, Trotta F.

Int J Pharm. 2017 Oct 15;531(2):470-479. doi: 10.1016/j.ijpharm.2017.06.072. Epub 2017 Jun 20. Review.

PMID:
28645630
27.

Italian consumption of plasma-derived factor VIII after the SIPPET study.

Traversa G, Trotta F.

Blood Transfus. 2017 May;15(3):283-284. doi: 10.2450/2017.0035-17. No abstract available.

28.

Cardiovascular safety of tiotropium Respimat vs HandiHaler in the routine clinical practice: A population-based cohort study.

Trotta F, Spila-Alegiani S, Da Cas R, Rajevic M, Conti V, Venegoni M, Rossi M, Traversa G.

PLoS One. 2017 Apr 21;12(4):e0176276. doi: 10.1371/journal.pone.0176276. eCollection 2017.

29.

Simulated presence therapy for dementia.

Abraha I, Rimland JM, Lozano-Montoya I, Dell'Aquila G, Vélez-Díaz-Pallarés M, Trotta FM, Cruz-Jentoft AJ, Cherubini A.

Cochrane Database Syst Rev. 2017 Apr 18;4:CD011882. doi: 10.1002/14651858.CD011882.pub2. Review.

PMID:
28418586
30.

Atorvastatin inhibits the immediate-early response gene EGR1 and improves the functional profile of CD4+T-lymphocytes in acute coronary syndromes.

Severino A, Zara C, Campioni M, Flego D, Angelini G, Pedicino D, Giglio AF, Trotta F, Giubilato S, Pazzano V, Lucci C, Iaconelli A, Ruggio A, Biasucci LM, Crea F, Liuzzo G.

Oncotarget. 2017 Mar 14;8(11):17529-17550. doi: 10.18632/oncotarget.15420.

31.

Enhanced cytotoxic effect of camptothecin nanosponges in anaplastic thyroid cancer cells in vitro and in vivo on orthotopic xenograft tumors.

Gigliotti CL, Ferrara B, Occhipinti S, Boggio E, Barrera G, Pizzimenti S, Giovarelli M, Fantozzi R, Chiocchetti A, Argenziano M, Clemente N, Trotta F, Marchiò C, Annaratone L, Boldorini R, Dianzani U, Cavalli R, Dianzani C.

Drug Deliv. 2017 Nov;24(1):670-680. doi: 10.1080/10717544.2017.1303856.

32.
33.

Systematic review of systematic reviews of non-pharmacological interventions to treat behavioural disturbances in older patients with dementia. The SENATOR-OnTop series.

Abraha I, Rimland JM, Trotta FM, Dell'Aquila G, Cruz-Jentoft A, Petrovic M, Gudmundsson A, Soiza R, O'Mahony D, Guaita A, Cherubini A.

BMJ Open. 2017 Mar 16;7(3):e012759. doi: 10.1136/bmjopen-2016-012759. Review. Erratum in: BMJ Open. 2017 Jul 17;7(7):e012759corr1.

34.

Erratum to: IROA: International Register of Open Abdomen, preliminary results.

Coccolini F, Montori G, Ceresoli M, Catena F, Ivatury R, Sugrue M, Sartelli M, Fugazzola P, Corbella D, Salvetti F, Negoi I, Zese M, Occhionorelli S, Maccatrozzo S, Shlyapnikov S, Galatioto C, Chiarugi M, Demetrashvili Z, Dondossola D, Yovtchev Y, Ioannidis O, Novelli G, Nacoti M, Khor D, Inaba K, Demetriades D, Kaussen T, Jusoh AC, Ghannam W, Sakakushev B, Guetta O, Dogjani A, Costa S, Singh S, Damaskos D, Isik A, Yuan KC, Trotta F, Rausei S, Martinez-Perez A, Bellanova G, Fonseca VC, Hernández F, Marinis A, Fernandes W, Quiodettis M, Bala M, Vereczkei A, Curado RL, Fraga GP, Pereira BM, Gachabayov M, Chagerben GP, Arellano ML, Ozyazici S, Costa G, Tezcaner T, Ansaloni L.

World J Emerg Surg. 2017 Mar 9;12:13. doi: 10.1186/s13017-017-0127-4. eCollection 2017.

35.

Comparative effectiveness and safety of erythropoiesis-stimulating agents (biosimilars vs originators) in clinical practice: a population-based cohort study in Italy.

Trotta F, Belleudi V, Fusco D, Amato L, Mecozzi A, Mayer F, Sansone M, Davoli M, Addis A.

BMJ Open. 2017 Mar 10;7(3):e011637. doi: 10.1136/bmjopen-2016-011637.

36.

Epicardial adipose tissue microbial colonization and inflammasome activation in acute coronary syndrome.

Pedicino D, Severino A, Ucci S, Bugli F, Flego D, Giglio AF, Trotta F, Ruggio A, Lucci C, Iaconelli A, Paroni Sterbini F, Biasucci LM, Sanguinetti M, Glieca F, Luciani N, Massetti M, Crea F, Liuzzo G.

Int J Cardiol. 2017 Jun 1;236:95-99. doi: 10.1016/j.ijcard.2017.02.040. Epub 2017 Feb 16.

PMID:
28268083
37.

Kawasaki disease and immunisation: A systematic review.

Phuong LK, Bonetto C, Buttery J, Pernus YB, Chandler R, Felicetti P, Goldenthal KL, Kucuku M, Monaco G, Pahud B, Shulman ST, Top KA, Trotta F, Ulloa-Gutierrez R, Varricchio F, de Ferranti S, Newburger JW, Dahdah N, Singh S, Bonhoeffer J, Burgner D; Brighton Collaboration Kawasaki Disease (KD) Working Group.

Vaccine. 2017 Mar 27;35(14):1770-1779. doi: 10.1016/j.vaccine.2016.09.033. Epub 2017 Mar 2. Review.

PMID:
28259442
38.

IROA: International Register of Open Abdomen, preliminary results.

Coccolini F, Montori G, Ceresoli M, Catena F, Ivatury R, Sugrue M, Sartelli M, Fugazzola P, Corbella D, Salvetti F, Negoi I, Zese M, Occhionorelli S, Maccatrozzo S, Shlyapnikov S, Galatioto C, Chiarugi M, Demetrashvili Z, Dondossola D, Yovtchev Y, Ioannidis O, Novelli G, Nacoti M, Khor D, Inaba K, Demetriades D, Kaussen T, Jusoh AC, Ghannam W, Sakakushev B, Guetta O, Dogjani A, Costa S, Singh S, Damaskos D, Isik A, Yuan KC, Trotta F, Rausei S, Martinez-Perez A, Bellanova G, Fonseca VC, Hernández F, Marinis A, Fernandes W, Quiodettis M, Bala M, Vereczkei A, Curado RL, Fraga GP, Pereira BM, Gachabayov M, Chagerben GP, Arellano ML, Ozyazici S, Costa G, Tezcaner T, Ansaloni L.

World J Emerg Surg. 2017 Feb 21;12:10. doi: 10.1186/s13017-017-0123-8. eCollection 2017. Erratum in: World J Emerg Surg. 2017 Mar 9;12 :13.

39.

Dissecting the role of the elongation factor 1A isoforms in hepatocellular carcinoma cells by liposome-mediated delivery of siRNAs.

Farra R, Scaggiante B, Guerra C, Pozzato G, Grassi M, Zanconati F, Perrone F, Ferrari C, Trotta F, Grassi G, Dapas B.

Int J Pharm. 2017 Jun 20;525(2):367-376. doi: 10.1016/j.ijpharm.2017.02.031. Epub 2017 Feb 14.

PMID:
28229942
40.

Dynamics and interactions of ibuprofen in cyclodextrin nanosponges by solid-state NMR spectroscopy.

Ferro M, Castiglione F, Pastori N, Punta C, Melone L, Panzeri W, Rossi B, Trotta F, Mele A.

Beilstein J Org Chem. 2017 Jan 27;13:182-194. doi: 10.3762/bjoc.13.21. eCollection 2017.

41.

[Equivalence, equity and evidence for the use of biosimilar drugs.]

Trotta F, Addis A.

Recenti Prog Med. 2017 Jan;108(1):11-13. doi: 10.1701/2624.26979. Italian.

PMID:
28151523
42.

Single organ cutaneous vasculitis: Case definition & guidelines for data collection, analysis, and presentation of immunization safety data.

Zanoni G, Girolomoni G, Bonetto C, Trotta F, Häusermann P, Opri R, Bonhoeffer J; Brighton Collaboration Single Organ Cutaneous Vasculitis Working Group.

Vaccine. 2016 Dec 12;34(51):6561-6571. doi: 10.1016/j.vaccine.2016.09.032. Epub 2016 Oct 28. Review. No abstract available.

PMID:
28029543
43.

Drug Delivery Nanoparticles in Treating Chemoresistant Tumor Cells.

Barrera G, Daga M, Ferrara B, Dianzani C, Pizzimenti S, Argenziano M, Cavalli R, Trotta F.

Curr Med Chem. 2017;24(42):4800-4815. doi: 10.2174/0929867323666161205122225. Review.

44.

O2 selective membranes based on a dextrin-nanosponge (NS) in a PVDF-HFP polymer matrix for Li-air cells.

Amici J, Alidoost M, Francia C, Bodoardo S, Martinez Crespiera S, Amantia D, Biasizzo M, Caldera F, Trotta F.

Chem Commun (Camb). 2016 Nov 17;52(94):13683-13686.

PMID:
27819076
45.

Non-Pharmacological Interventions to Prevent or Treat Delirium in Older Patients: Clinical Practice Recommendations The SENATOR-ONTOP Series.

Abraha I, Rimland JM, Trotta F, Pierini V, Cruz-Jentoft A, Soiza R, O'Mahony D, Cherubini A.

J Nutr Health Aging. 2016;20(9):927-936. Review.

PMID:
27791223
46.

The diagnosis and clinical management of the neuropsychiatric manifestations of lupus.

Govoni M, Bortoluzzi A, Padovan M, Silvagni E, Borrelli M, Donelli F, Ceruti S, Trotta F.

J Autoimmun. 2016 Nov;74:41-72. doi: 10.1016/j.jaut.2016.06.013. Epub 2016 Jul 12. Review.

PMID:
27427403
47.

Characterisation of peripheral blood mononuclear cell microRNA in early onset psoriatic arthritis.

Ciancio G, Ferracin M, Saccenti E, Bagnari V, Farina I, Furini F, Galuppi E, Zagatti B, Trotta F, Negrini M, Govoni M.

Clin Exp Rheumatol. 2017 Jan-Feb;35(1):113-121. Epub 2016 Oct 7.

PMID:
27749230
48.

Molecularly imprinted cyclodextrin nanosponges for the controlled delivery of L-DOPA: perspectives for the treatment of Parkinson's disease.

Trotta F, Caldera F, Cavalli R, Soster M, Riedo C, Biasizzo M, Uccello Barretta G, Balzano F, Brunella V.

Expert Opin Drug Deliv. 2016 Dec;13(12):1671-1680. Epub 2016 Oct 24.

49.

Intussusception hospitalizations incidence in the pediatric population in Italy: a nationwide cross-sectional study.

Trotta F, Da Cas R, Bella A, Santuccio C, Salmaso S.

Ital J Pediatr. 2016 Sep 27;42(1):89.

50.

Transport Properties of Ibuprofen Encapsulated in Cyclodextrin Nanosponge Hydrogels: A Proton HR-MAS NMR Spectroscopy Study.

Ferro M, Castiglione F, Punta C, Melone L, Panzeri W, Rossi B, Trotta F, Mele A.

J Vis Exp. 2016 Aug 15;(114). doi: 10.3791/53769.

Supplemental Content

Loading ...
Support Center